📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-14 19:52
222 analysed today
FollowTelegram
222
Today
150,661
All-time analysed
43,155
Positive
6,696
Negative
92,043
Neutral
8,699
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
13 announcements match the current filters (relevance ≥ 5).
Narmada Agrobase Reports Q1 FY27 Results; Reports Nil Deviation in Issue Proceeds
Narmada Agrobase Limited approved its standalone and consolidated unaudited financial results for the quarter ended June 30, 2026, at its board meeting on August 14, 2026. The company also submitted a statement of Nil deviation or variation in the utilization of proceeds raised via its prospectus dated September 17, 2024. Disclosures regarding outstanding debt defaults and modified audit opinions were marked as not applicable.
Confidence: LOW
What changedNarmada Agrobase completed its integrated financial filing and quarterly results approval for the quarter ended June 30, 2026.
Why it mattersConfirms regulatory compliance, valid review by statutory auditors, and proper deployment of capital raised without deviations from stated prospectus objects.
Financial Period Ended: 30th June, 2026Prospectus Issue Date: September 17, 2024Deviation in Issue Proceeds: NILTotal Debt (Context): Rs 10 Cr
📅 Short termNeutral; stock performance will depend on underlying revenue and profit margins from the detailed quarterly accounts.
📈 Long termLimited direct impact from the filing itself; tracking capacity utilization improvements towards the 40,000 TPA target remains key.
⚠ Risk flags
- Detailed profit and loss figures omitted in text extract
- Commodity price volatility in cottonseed inputs
Key Highlights
Approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2026
Confirmed NIL deviation in the use of issue proceeds from the prospectus dated September 17, 2024
Board meeting held on August 14, 2026, commenced at 4:00 PM and concluded at 6:30 PM
Reported zero outstanding loan/debt defaults as per regulatory disclosure format
👀 What to Watch
Review detailed tabular quarterly financial statements once full annexures are accessible to assess revenue growth and margin trends against agri-commodity cost pressures.
100% Shareholder Approval to Alter Rights Issue Fund Utilization Objects
Shareholders of Narmada Agrobase have unanimously approved a special resolution to modify the utilization of funds raised through its September 2024 Rights Issue. A total of 2.29 crore votes were cast via postal ballot, with 100% in favor of the alteration. This change allows the company to redirect capital originally earmarked for specific objects to new requirements, providing management with financial flexibility. The company currently operates at 50% capacity utilization and maintains a net worth of Rs 59 Cr.
Confidence: HIGH
What changedShareholders have formally authorized the company to deviate from the original spending plan outlined in the 2024 Rights Issue Letter of Offer.
Why it mattersWhile it provides management with flexibility to address current business needs, a change in objects can sometimes indicate delays or shifts in the original strategic roadmap.
Total Valid Votes: 2,28,85,776Approval Rate: 100%Original Rights Issue Date: 17th September, 2024Net Worth: Rs 59 Cr
📅 Short termThe stock may see neutral to slightly cautious sentiment as the market awaits clarity on the specific new use of funds.
📈 Long termThe structural impact depends on whether the reallocated capital is deployed into higher-margin value-added products like mineral blends or high-fat feeds as per the company's growth strategy.
⚠ Risk flags
- Reallocation of funds may signal that original project timelines or objectives were not met
Key Highlights
100% of the 2,28,85,776 valid votes were cast in favor of the special resolution
The resolution modifies the objects of the Rights Issue originally dated September 17, 2024
The voting process concluded on July 29, 2026, following a 30-day e-voting window
Company maintains a debt-to-equity ratio of 0.17 with a net worth of Rs 59 Cr
👀 What to Watch
Investors should monitor subsequent disclosures to identify the specific new projects or operational needs the Rights Issue proceeds are now being directed toward.
Narmada Agrobase Shareholders Approve 100% Variation in Rights Issue Fund Utilization
Shareholders of Narmada Agrobase have passed a special resolution to alter the objects of the Rights Issue originally detailed in the Letter of Offer dated September 17, 2024. The resolution was approved with 100% of the 2.28 crore valid votes cast in favor via a postal ballot ending July 29, 2026. This approval grants the company flexibility to reallocate net proceeds from the equity issuance, though specific new allocation details were not provided in this results filing. Investors should note this change in capital allocation strategy relative to the company's Rs 59 crore net worth.
Confidence: HIGH
What changedThe company has obtained formal shareholder approval to change the intended use of funds raised through its 2024 Rights Issue.
Why it mattersChanging the objects of a fundraise allows management to pivot capital towards different business needs, which could either improve operational efficiency or signal a departure from original growth plans.
Total Valid Votes Cast: 2,28,85,776Approval Percentage: 100%Original Rights Issue Date: 17th September, 2024Company Net Worth: Rs 59 Cr
📅 Short termThe stock is likely to remain stable as this is a procedural approval of a previously proposed change in fund usage.
📈 Long termThe long-term impact depends on whether the reallocated funds are deployed into high-margin specialty nutrition feeds or used for working capital to manage cottonseed price volatility.
⚠ Risk flags
- Lack of specific detail on the new objects in this filing
- Potential diversion of funds from original long-term capex
Key Highlights
100% of the 2,28,85,776 valid votes were cast in favor of altering the Rights Issue objects.
The resolution modifies the utilization of funds from the Rights Issue initiated via the Letter of Offer dated September 17, 2024.
The remote e-voting process concluded on July 29, 2026, with the Scrutinizer's report finalized on July 30, 2026.
The cut-off date for determining shareholder eligibility was June 26, 2026.
👀 What to Watch
Investors should monitor upcoming quarterly filings to identify the specific new 'objects' for which the funds are being used, particularly if they support the company's stated goal of increasing capacity utilization from 50%.
Narmada Agrobase Approves Stock Split and 4-Year Auditor Term at 14th AGM
Narmada Agrobase Limited concluded its 14th Annual General Meeting on July 18, 2026, where shareholders approved the sub-division (stock split) of equity shares. The company also re-appointed Jain Kedia and Sharma as Statutory Auditors for a four-year term. Management reiterated a growth target of 35%, supported by plans to increase capacity utilization from the current 50% level. The meeting confirmed the adoption of FY26 financial statements with no adverse remarks from auditors.
Confidence: HIGH
What changedThe company has received shareholder mandate for a stock split and secured its statutory auditing team for the next four years.
Why it mattersThe stock split is intended to enhance retail participation by making shares more affordable, while the focus on utilizing existing 40,000 TPA capacity suggests potential for margin expansion through operating leverage.
Auditor Term: 4 yearsInstalled Capacity: 40,000 TPACapacity Utilization (H1 FY26): ~50%Expected Growth Rate: 35%Debt to Equity: 0.17
📅 Short termThe stock split approval is likely to create positive sentiment and improve trading liquidity in the coming weeks.
📈 Long termLong-term value creation depends on the successful execution of the 35% growth strategy and diversifying into dairy-deficit Asia-Pacific markets.
⚠ Risk flags
- Raw material price volatility (cottonseed)
- High competition in the livestock feed sector
Key Highlights
Shareholders approved the sub-division (stock split) of equity shares to improve liquidity
Re-appointment of Statutory Auditors confirmed for a further term of 4 years
Current installed capacity stands at 40,000 TPA with significant headroom as utilization was ~50% in H1 FY26
Company targeting a 35% growth rate by expanding dealer networks in Maharashtra and MP
Meeting concluded efficiently within 19 minutes (11:30 AM to 11:49 AM)
👀 What to Watch
Investors should watch for the announcement of the record date and the specific ratio for the stock split, and monitor quarterly volume growth to see if capacity utilization moves above the 50% mark.
₹7.70 Cr Reallocation: Narmada Agrobase to Repay SBI Debt Instead of New Plant Capex
Narmada Agrobase is seeking shareholder approval to reallocate ₹7.70 crore from its September 2024 Rights Issue proceeds. Originally earmarked for land acquisition and the construction of an Oil Mill Plant, these funds will now be used to repay an outstanding term loan from the State Bank of India. The company has already utilized ₹26.88 crore of the total ₹34.58 crore net proceeds for working capital and general corporate purposes. This move indicates a shift in priority from immediate physical capacity expansion to balance sheet deleveraging.
Confidence: HIGH
What changedThe company is pivoting from a planned capital expenditure (Oil Mill Plant) to debt repayment using unspent Rights Issue proceeds.
Why it mattersWhile debt repayment strengthens the balance sheet (addressing ₹7.70 Cr of the ₹10 Cr total debt), it suggests a delay or cancellation of the physical expansion originally promised to shareholders during the fundraise.
Reallocated Amount: ₹7.70 CrTotal Rights Issue Proceeds: ₹34.58 CrReallocation vs Total Debt: ~77%Reallocation vs Net Worth: ~13%Utilized Funds to Date: ₹26.88 Cr
📅 Short termNeutral to slightly cautious as the market digests the cancellation of a growth-oriented capex project in favor of debt reduction.
📈 Long termLimited impact on immediate operations as current capacity utilization is only ~50%, but the cancellation of the new plant may cap future volume growth beyond the existing 40,000 TPA limit.
⚠ Risk flags
- Change in use of proceeds
- Potential slowdown in growth strategy
- Cancellation of planned capex
Key Highlights
₹7.70 crore unspent balance from the 2024 Rights Issue to be reallocated to debt repayment.
₹34.58 crore total net proceeds were raised via the Rights Issue dated September 17, 2024.
₹26.88 crore has already been utilized for working capital (₹17.87 Cr) and general corporate purposes (₹9.01 Cr).
100% of the remaining capex budget for the Oil Mill Plant is being diverted to settle SBI term loans.
Voting period for this special resolution ends on July 29, 2026, with results expected shortly after.
👀 What to Watch
Monitor the voting results on July 29, 2026, and evaluate if the cancellation of the new Oil Mill Plant affects the company's long-term 35% growth target.
Narmada Agrobase Approves 1:2 Stock Split and FY26 Audited Financial Results
Narmada Agrobase Limited has approved its audited financial results for the quarter and year ended March 31, 2026, with an unmodified audit opinion. The Board has proposed a stock split, sub-dividing each equity share of face value ₹10 into two equity shares of face value ₹5 each, pending shareholder approval. The company's authorized share capital will be adjusted to ₹38 crores, consisting of 7.6 crore shares. Additionally, the company confirmed it has no defaults on any loans or debt securities.
Key Highlights
Approved sub-division of equity shares from a face value of ₹10 to ₹5 per share (1:2 split).
Authorized share capital set at ₹38,00,00,000 divided into 7,60,00,000 equity shares of ₹5 each.
Statutory auditors issued an unmodified opinion on the standalone financial results for FY26.
Confirmed zero defaults on existing loans and debt securities as of March 31, 2026.
Board meeting concluded at approximately 7:00 PM on May 29, 2026.
👀 What to Watch
Investors should monitor the announcement of the record date for the stock split and review the full financial statements to evaluate the company's year-on-year growth and profitability.
Narmada Agrobase to Vary Rights Issue Objects; Re-appoints Statutory Auditors for 4 Years
Narmada Agrobase Limited has approved a variation in the utilization of funds raised through its September 2024 Rights Issue, subject to shareholder approval. The board has also re-appointed Jain Kedia and Sharma as Statutory Auditors for a four-year term and appointed Mr. Rajesh Kumar as the Internal Auditor for FY 2026-27. Additionally, the company's 14th Annual General Meeting (AGM) is scheduled for July 18, 2026, to discuss these resolutions and the FY 2026 Director's Report.
Key Highlights
Approved variation in the objects of the Rights Issue originally dated September 17, 2024, pending shareholder consent.
Re-appointed Jain Kedia and Sharma as Statutory Auditors for a further term of 4 years.
Appointed Mr. Rajesh Kumar as Internal Auditor for the financial year 2026-27.
Scheduled the 14th Annual General Meeting (AGM) for July 18, 2026, at 11:30 A.M. via video conferencing.
Approved the Director's Report and other annexures for the financial year ended March 31, 2026.
👀 What to Watch
Investors should review the upcoming AGM notice to understand the specific reasons for the variation in the Rights Issue objects to ensure capital is being deployed effectively. Monitor the company's progress on its revised capital allocation strategy.
Narmada Agrobase Promoters Declare Zero New Encumbrances for FY26; Hold 50.30% Stake
Neerajkumar Sureshchandra Agrawal, representing the promoter group of Narmada Agrobase Limited, has submitted the annual disclosure under SEBI (SAST) Regulations for the financial year ended March 31, 2026. The declaration confirms that the promoter group and Persons Acting in Concert (PAC) have not created any new encumbrances on their shares during the year. Collectively, the promoter group holds 1,90,80,438 shares, which accounts for 50.30% of the company's total voting capital. This filing is a routine but essential transparency measure regarding promoter share pledging.
Key Highlights
Promoter group and PACs collectively hold 1,90,80,438 shares, representing a 50.30% stake in the company.
Official declaration confirms no new share pledges or encumbrances were made during the financial year ended March 31, 2026.
Neerajkumar S Agarwal remains the largest individual promoter with a 25.07% stake (95,09,976 shares).
Other significant promoter holdings include Abhishek S Agarwal (6.27%) and Raxita Abhishek Agrawal (5.87%).
👀 What to Watch
Investors can take comfort in the fact that the majority shareholders have not pledged additional shares, indicating financial stability at the promoter level. No immediate action is required as this is a standard annual compliance filing.
Narmada Agrobase Incorporates Wholly Owned Subsidiary Narmada Bio Feed Pvt Ltd
Narmada Agrobase Limited has announced the incorporation of a new wholly owned subsidiary, Narmada Bio Feed Private Limited, as of May 6, 2026. The subsidiary will focus on the cattle feed industry, including poultry, aqua, and bio feed, as well as agro-processing and biotechnology. The initial investment for the 100% stake is ₹1 lakh, representing 10,000 shares. This move indicates a strategic expansion into specialized animal nutrition and renewable energy products like biogas and compost.
Key Highlights
Incorporated Narmada Bio Feed Private Limited as a 100% wholly owned subsidiary on May 6, 2026
Initial capital subscription of ₹1 lakh for 10,000 shares at par value
Business scope includes production and distribution of cattle, poultry, aqua, and bio feed
Subsidiary plans to utilize agricultural and animal waste for manufacturing biogas and renewable energy products
Expansion covers biotechnology and agro-processing sectors within the animal nutrition industry
👀 What to Watch
Investors should view this as a positive step toward diversification and monitor the subsidiary's future capital expenditure and revenue contribution. Watch for updates on the commencement of operations in the bio-feed and renewable energy segments.
Narmada Agrobase Investor Update: FY25 Revenue at ₹66.34 Cr; 50% Capacity Utilization
Narmada Agrobase reported FY25 revenue of ₹6,633.91 Lakhs and a PAT of ₹408.80 Lakhs, highlighting steady growth in its cattle feed and cottonseed segments. The company currently utilizes only 50% of its 40,000 TPA capacity, suggesting significant organic growth potential as it expands into new regions like Maharashtra and Punjab. With a strong 99% client retention rate and a diversified product portfolio, the company is positioning itself for both domestic and export market growth in Southeast Asia and the Middle East.
Key Highlights
FY25 Revenue stood at ₹6,633.91 Lakhs with an EBITDA of ₹623.82 Lakhs and PAT of ₹408.80 Lakhs
Current production utilization is at 50% of the 40,000 TPA installed capacity, providing headroom for growth
Revenue mix is well-balanced between Cattle Feed (52% or ₹34.15 Cr) and Cottonseed segments (48% or ₹31.52 Cr)
Distribution network includes over 1,000 retail points and 150 wholesale points across core markets
Strategic focus on expanding exports to Southeast Asia, Middle East, and Africa to diversify revenue
👀 What to Watch
Investors should monitor the company's ability to ramp up capacity utilization from 50% to higher levels, which would improve operating leverage. The success of geographical expansion into Northern India and international markets will be the primary growth driver to watch.
Narmada Agrobase Q3 FY26 Revenue Surges 52.86% YoY to ₹2,164.31 Lakhs
Narmada Agrobase reported a significant 52.86% YoY increase in total income for Q3 FY26, reaching ₹2,164.31 lakhs, driven by volume expansion in the cattle feed segment. However, profitability growth remained nearly flat, with Net Profit rising only 1.35% to ₹101.34 lakhs compared to ₹100.00 lakhs in the previous year. For the nine-month period (9M FY26), the company achieved a total income of ₹4,533.82 lakhs and a Net Profit of ₹305.91 lakhs. The results indicate strong market demand but suggest significant pressure on operating margins.
Key Highlights
Total Income for Q3 FY26 grew by 52.86% YoY to ₹2,164.31 lakhs from ₹1,415.87 lakhs.
Net Profit for Q3 FY26 stood at ₹101.34 lakhs, showing a marginal increase of 1.35% YoY.
9M FY26 Total Income reached ₹4,533.82 lakhs with a cumulative Net Profit of ₹305.91 lakhs.
EBITDA for Q3 FY26 was ₹167.49 lakhs, representing a slight growth of 0.87% YoY.
The company maintains an ISO 9001:2015 certification and is focusing on expanding into Asia-Pacific export markets.
👀 What to Watch
Investors should exercise caution as the massive 52% revenue growth did not translate into meaningful profit growth, indicating a sharp contraction in margins. Monitor the company's ability to manage raw material costs and improve operational efficiency in upcoming quarters.
Narmada Agrobase Q3 Revenue Jumps 53% YoY to ₹21.15 Cr; Net Profit Steady at ₹1.01 Cr
Narmada Agrobase reported a strong 53% year-on-year increase in revenue for the quarter ended December 31, 2025, reaching ₹21.15 crore. However, net profit remained nearly flat at ₹1.01 crore compared to ₹1.00 crore in the previous year's corresponding quarter, reflecting significant margin pressure from rising operational costs. For the nine-month period ending December 2025, net profit actually declined by 7.5% to ₹3.06 crore. The company is currently deploying ₹36.58 crore raised via a Rights Issue, with ₹7.70 crore earmarked for new plant machinery and ₹17.87 crore for working capital.
Key Highlights
Revenue from operations grew 52.8% YoY to ₹21.15 crore in Q3 FY26.
Net profit for the quarter stood at ₹1.01 crore, showing marginal growth from ₹1.00 crore YoY.
Total expenses surged to ₹20.23 crore in Q3 FY26 from ₹12.76 crore in Q3 FY25, primarily driven by raw material costs.
Nine-month (9M) net profit decreased to ₹3.06 crore from ₹3.31 crore in the prior year period.
Rights Issue proceeds of ₹36.58 crore are being utilized for capital expenditure and working capital, with some funds currently held in fixed deposits.
👀 What to Watch
Investors should monitor the company's operating margins, as the current trend shows that massive revenue growth is not trickling down to the bottom line due to rising costs. The successful integration of the new plant machinery funded by the Rights Issue will be the primary catalyst for future margin expansion.
Narmada Agrobase Q3 Revenue Jumps 53% YoY to ₹21.15 Cr; Net Profit Remains Flat at ₹1.01 Cr
Narmada Agrobase reported a significant 53% YoY increase in revenue from operations, reaching ₹21.15 crore for the quarter ended December 31, 2025. Despite the strong top-line growth, net profit remained nearly stagnant at ₹1.01 crore compared to ₹1.00 crore in the previous year's corresponding quarter, reflecting margin pressure. The company has utilized ₹28.71 crore of its ₹36.58 crore Rights Issue proceeds, primarily for working capital and corporate purposes. A balance of ₹7.86 crore intended for capital expenditure on new machinery remains unspent and is currently held in fixed deposits.
Key Highlights
Revenue from operations increased 53% YoY to ₹21.15 crore from ₹13.84 crore.
Net profit for the quarter stood at ₹1.01 crore, showing negligible growth from ₹1.00 crore YoY.
Total expenses rose sharply to ₹20.23 crore, largely driven by ₹17.17 crore in raw material costs.
Rights Issue proceeds of ₹17.87 crore for working capital and ₹9.01 crore for general corporate purposes have been fully utilized.
Capital expenditure of ₹7.70 crore for a new plant and machinery is yet to be deployed and is parked in FDs.
👀 What to Watch
Investors should monitor the company's ability to manage rising raw material costs which are currently offsetting strong revenue growth. The future commissioning of the new plant using the remaining Rights Issue funds will be a critical milestone for capacity expansion.
